Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.

doi:10.1016/j.ijcard.2021.10.138

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.

International journal of cardiology - 15 Dec 2021

Cesaro Arturo, Gragnano Felice, Calabrò Paolo, Moscarella Elisabetta, Santelli Francesco, Fimiani Fabio, Patti Giuseppe, Cavallari Ilaria, Antonucci Emilia, Cirillo Plinio, Pignatelli Pasquale, Palareti Gualtiero, Pelliccia Francesco, Bossone Eduardo, Pengo Vittorio, Gresele Paolo, Marcucci Rossella

Abstract excerpt

AIM: To analyze the prevalence and clinical implications of the eligibility criteria for prolonged dual antithrombotic therapy with ticagrelor 60 mg twice daily and/or rivaroxaban 2.5 mg twice daily in a contemporary real-world ACS registry. METHODS: Patients from the START-ANTIPLATELET registry (NCT02219984) were stratified according to the eligibility criteria of the PEGASUS and COMPASS studies to investigate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspirin

Share to Fibrinolytic Agents

Share to Percutaneous Coronary Intervention

Share to Platelet Aggregation Inhibitors

Share to Prevalence

Share to Registries

Share to Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 34695525
DOI: 10.1016/j.ijcard.2021.10.138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.PMID 34695525Read ↗

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity Read ↗

Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSemantic proximity Read ↗

Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity Read ↗

Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity Read ↗

Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES TrialSemantic proximity Read ↗

Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity Read ↗

Genotype- and phenotype-directed antiplatelet therapy selection in patients with acute coronary syndromes.Semantic proximity Read ↗

Stroke rates, risk factors, and aspirin prescribing trends in the Canadian Fabry Disease Initiative cohortSemantic proximity Read ↗

Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA‐AFSemantic proximity Read ↗

Management of antithrombotic agents during emergency endoscopy for upper gastrointestinal bleeding: A propensity score matching analysisSemantic proximity Read ↗

Contemporary burden of atrial fibrillation in mechanical thrombectomy stroke patients in the United StatesSemantic proximity Read ↗

Bleeding in cardiac patients prescribed antithrombotic drugs: Electronic health record phenotyping algorithms, incidence, trends and prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.